Evidence Level
Thiamine's role in metabolism and neurological function is well-established. Stracke et al. (2008) demonstrated in an RCT that benfotiamine at 300 mg/day significantly improved neuropathy symptom scores in type 1 and type 2 diabetic patients. A 2013 systematic review by Whitfield et al. found that thiamine deficiency is underdiagnosed in developed countries, particularly among alcoholics (up to 80% prevalence), elderly in institutions, and patients with heart failure. Schoenenberger et al. (2012) showed that thiamine supplementation improved left ventricular ejection fraction in heart failure patients with thiamine deficiency.